Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05227144
Title Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ORIC Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
James R. Berenson, MD, Inc. COMPLETED West Hollywood California 90069 United States Details
Northside Hospital Cancer Institute RECRUITING Atlanta Georgia 30342 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinical Rochester RECRUITING Rochester Minnesota 55905 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
The Charlotte-Mecklenburg Hospital Authority d/b/a Atrium Health RECRUITING Charlotte North Carolina 28203 United States Details
Swedish Health Services RECRUITING Seattle Washington 98107 United States Details
Princess Margaret Cancer Research Center/University Health Network RECRUITING Toronto Ontario Canada Details
*Shaded cells indicate that there was no data available from for the field